Multiple myeloma/hypercalcemia
Multiple myeloma, a cancer of plasma cells, is associated with excessive tumor-induced, osteoclast-mediated bone destruction. Hypercalcemia remains the most frequent metabolic complication of myeloma in patients, and excessive osteolysis plays a major contributory role in its pathogenesis. The clini...
Main Author: | |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2007
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924519/ |